Literature DB >> 7738032

Calpains are activated in necrotic fibers from mdx dystrophic mice.

M J Spencer1, D E Croall, J G Tidball.   

Abstract

Death of dystrophin-deficient muscle purportedly results from increases in [Ca]in that cause the activation of calpains. We have tested whether calpains play a role in this process by assaying for changes in calpain concentration and activation in peak necrotic mdx mice (4 weeks of age) and in completely regenerated mdx mice (14 weeks of age). Biochemical fractionation and immunoblotting with epitope-specific antisera allowed measurement of the concentrations of m- and mu-calpains and the extent of autoproteolytic modification. Our findings show that total calpain concentration is elevated in both 4-week and 14-week mdx mice. This increase in concentration was shown to result primarily from a significant increase in m-calpain concentration at 4 weeks. Northern analysis demonstrated that neither m- nor mu-calpain mRNA concentrations differed between mdx and controls suggesting that the increased calpain concentration results from post-translational regulation. Immunoblotting with antibodies directed against amino-terminal peptides revealed an increase in autoproteolysis of mu-calpain, indicative of increased activation. The extent of autoproteolysis of mu-calpain returns to control levels during regeneration. This is not a consequence of increased calpastatin mRNA or protein. The findings reported here support a role for calpains in both the degenerative and regenerative aspects of mdx dystrophy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7738032     DOI: 10.1074/jbc.270.18.10909

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

Review 1.  Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse.

Authors:  J M Gillis
Journal:  J Muscle Res Cell Motil       Date:  1999-10       Impact factor: 2.698

2.  Contractile function, sarcolemma integrity, and the loss of dystrophin after skeletal muscle eccentric contraction-induced injury.

Authors:  Richard M Lovering; Patrick G De Deyne
Journal:  Am J Physiol Cell Physiol       Date:  2003-10-01       Impact factor: 4.249

3.  Changes in proteolytic enzymes mRNAs and proteins relevant for meat quality during myogenesis and hypoxia of primary bovine satellite cells.

Authors:  You Bing Yang; Muthuraman Pandurangan; InHo Hwang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-05-31       Impact factor: 2.416

Review 4.  What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease?

Authors:  Jennifer Manning; Dervla O'Malley
Journal:  J Muscle Res Cell Motil       Date:  2015-02-11       Impact factor: 2.698

5.  Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle.

Authors:  Sanjeewa A Goonasekera; Chi K Lam; Douglas P Millay; Michelle A Sargent; Roger J Hajjar; Evangelia G Kranias; Jeffery D Molkentin
Journal:  J Clin Invest       Date:  2011-03       Impact factor: 14.808

Review 6.  Ryanodine receptor patents.

Authors:  Alexander Kushnir; Andrew R Marks
Journal:  Recent Pat Biotechnol       Date:  2012-12

7.  Enhanced Ca²⁺ influx from STIM1-Orai1 induces muscle pathology in mouse models of muscular dystrophy.

Authors:  Sanjeewa A Goonasekera; Jennifer Davis; Jennifer Q Kwong; Federica Accornero; Lan Wei-LaPierre; Michelle A Sargent; Robert T Dirksen; Jeffery D Molkentin
Journal:  Hum Mol Genet       Date:  2014-02-20       Impact factor: 6.150

Review 8.  Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Authors:  Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  ILAR J       Date:  2014

Review 9.  Emerging role of protein kinase C in energy homeostasis: A brief overview.

Authors:  Kamal D Mehta
Journal:  World J Diabetes       Date:  2014-06-15

10.  Null mutation of gp91phox reduces muscle membrane lysis during muscle inflammation in mice.

Authors:  Hal X Nguyen; James G Tidball
Journal:  J Physiol       Date:  2003-10-10       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.